The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phosphorylated Akt and MAPK expression in primary tumors and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab.
Riccardo Giampieri
No relevant relationships to disclose
Mario Scartozzi
No relevant relationships to disclose
Elena Maccaroni
No relevant relationships to disclose
Alessandra Mandolesi
No relevant relationships to disclose
Simona Biagetti
No relevant relationships to disclose
Simona Alfonsi
No relevant relationships to disclose
Lucio Giustini
No relevant relationships to disclose
Cristian Loretelli
No relevant relationships to disclose
Luca Faloppi
No relevant relationships to disclose
Maristella Bianconi
No relevant relationships to disclose
Alessandro Bittoni
No relevant relationships to disclose
Michela Del Prete
No relevant relationships to disclose
Stefano Cascinu
No relevant relationships to disclose
Francesca Giorgi
No relevant relationships to disclose